News Archive
CEVEC announces new license agreement for its AAV manufacturing technology ELEVECTA® in gene therapy
CEVEC Pharmaceuticals GmbH (CEVEC) today announced the signing of a license agreement with Biogen Inc. (Biogen; Nasdaq: BIIB) for the use of CEVEC’s proprietary ELEVECTA® Technology for the manufacturing of adeno‐associated virus (AAV) vectors for gene therapy applications.
Miracor Medical raises 24M€
Funds will be used for clinical studies and initiation of commercialization
Permanent Link to Laboratory IT solution provider Labforward announces major rebranding at BCEIA in Beijing, China
At the Beijing Conference and Exhibition on Instrument Analysis (BCEIA), a leading Chinese trade fair for laboratory instruments, Labforward today announced a major rebranding to unify its products under a clear, clean identity. From today, the product cubuslab, an Internet-of-Things (IoT) platform for laboratory devices, will be known as Laboperator. The electronic lab notebook software (ELN) Labfolder will retain its original name.